1S9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seres Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.2 EUR Market Closed

Market Cap: €30.3m

S	Seres Therapeutics Inc F:1S9	US
	Wijaya Karya Bangunan Gedung Tbk PT IDX:WEGE	ID
E	Equifax Inc XMUN:EFX	US
B	Bank of America Corp SIX:BAC	US
	Hisamitsu Pharmaceutical Co Inc OTC:HTSUY	JP
	Faraday Copper Corp TSX:FDY	CA
L	Lloyds Banking Group PLC F:LLD	UK

Profitability Summary

Seres Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4.154%

Negative 3Y Average Operating Margin

-8.880%

Declining Operating Margin

-63% > -4.154%

Negative Net Margin

-1.193%

Negative 3Y Average Net Margin

-533%

Declining Net Margin

-119% > -1.193%

Negative Free Cash Flow Margin

-2.724%

Negative 3Y Average Free Cash Flow Margin

-2.189%

Declining Free Cash Flow Margin

-103% > -2.724%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-79%

Declining ROIC

-72% > -86%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.